uSTEM was created following the innovative vision of a young group of highly experienced biotechnology professionals and scientists, devoted to the research and development of new cells reprogramming methods.
Established in September 2016 thanks to the joint venture between OPKO Ireland Limited, a branch of the international healthcare firm OPKO Health, Inc., and the Italian startup company Onyel Biotech S.r.l, uSTEM is a dynamic and innovative startup company.
Its central position in the vibrant scientific and technological research park of Padova, strategically connects uSTEM with the University of Padova, the Institute of Pediatric Research, the Venetian Institute of Molecular Medicine and the other local research institutes.
uSTEM also benefits of the international experience of its founders, who have been able to establish long-lasting partnerships with renowned centers of excellence.
OPKO Health, Inc. is a multinational pharmaceutical & diagnostics company aiming to establish leading positions in the healthcare sector. It is quoted on the Nasdaq Stock Market and Tel Aviv stock markets.
ONYEL Biotech S.r.l. is an Italian startup, created thanks to the support of the Venetian Institute of Molecular Medicine (Padova, Italy). Onyel Biotech S.r.l. was founded by Professor Nicola Elvassore of the University of Padova, and by researchers Onelia Gagliano and Elena Serena, of the Venetian Institute of Molecular Medicine and the University of Padova.